Abstract
Intoxication has resulted from absorption of toxic amounts of organophosphorus anticholinesterase (anti-ChE) compounds during preparation or use as insecticides or chemical warfare agents, or as pharmaceutical agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature
Annis, J. W., and J. W. Williams: Change in electrolytes in case of parathion poisoning. J. Amer. med. Ass. 152, 594–596 (1953).
Aranow, H. jr., P. F. A. Hoefer and L. P. Rowland: The long-acting anticholinesterase drugs in the management of myasthenia gravis. J. chron. Dis. 6, 113–115 (1958).
Askew, B. M.: Oximes and hydroxamic acids as antidotes in anticholinesterase poisoning. Brit. J., Pharmacol. 11, 417–423 (1956).
Brit. J., D. R. Davies, A. L. Green and R. Holmes: The nature of the toxicity of 2–oxo-oximes. Brit. J. Pharmacol. 11, 424–27 (1956).
Augustinsson, K. B.: The normal variation of human blood cholinesterase activity. Acta physiol. scand. 35, 40–52 (1955).
Baetjer, A. M., and R. Smith: Effect of environmental temperature on reaction of mice to Parathion, an anticholinesterase agent. Amer. J. Physiol. 86, 39–46 (1956).
Baker, J. P., and J. D. Farley: Toxic psychosis following atropine eye-drops. Brit. med. J. 1958 II, 1390–1391.
Barnes, J. M.: Toxic hazards of certain pesticides to man. Wld. Hlth. Org. Monogr. Ser. (1953).
Barnes, J. M., and F. A. Denz: Experimental demyelination with organo-phosphorus compounds. J. Path. Bact. 65, 597–605 (1953).
Barnes, J. M., and J. I. Duff: The role of cholinesterase at the myoneural junction. Brit. J. Pharmacol. 8, 334–339 (1953).
Barstad, J. A. B.: The effect of d-tubocurarine on the neuromuscular blocks caused by diisopropylfluorophosphate and acetylcholine. Arch. int. Pharmacodyn. 107, 4–20 (1956).
Beck, I. T.: Pharmacological study of injected cholinesterase. Brit. J. Pharmacol. 6, 144–154 (1951).
Bergner, D. H., and S. H. Durlacher: Histochemical detection of fatal anticholinesterase poisoning Amer. J. Path. 27, 1011–1021 (1951).
Berry, W. K., and E. C. Lovett: Cholinesterase and neuromuscular block. J. Physiol. (Lond.) 115, 46 (1951).
Bidstrup, P. L., J. A. Bonnell, A. G. Beckett: Paralysis following poisoning by a new organic phosphorus insecticide (Mipafox). Brit. Med. J. 1953 I, 1068.
Bidstrup, L. P.: Anticholinesterase paralysis in man following poisoning by cholinesterase inhibitors. Chem. and Ind. 1954, 675–676.
Blank, I. H., R. D. Griesemer and E. Gould: The penetration of an anticholinesterase agent (sarin) into skin. Rate of penetration into excised human skin. J. invest. Derm. 29, 299–309 (1957).
Brown, R. V., A. M. Kunkel, L. M. Somers and J. H. Wills: Pyridine-2-aldoxime methiodide in the treatment of poisoning by sarin or tabun, with notes on its pharmacology. J. Pharmacol, exp. Ther. 120, 276–284 (1957).
Burgen, A. S. V., and F. Hobbiger: The inhibition of cholinesterases by alkylphosphates and alkylphenolphosphates. Brit. J. Pharmacol. 6, 593–605 (1951).
Burns, B. D., and W. D. M. Paton: Depolarization of the motor end-plate by decamethonium and acetylcholine. J. Physiol. (Lond.) 115, 41 (1951).
Callaway, S., and D. R. Davies: The association of blood cholinesterase levels with the susceptibility of animals to Sarin and Ethyl Pyrophosphate poisoning. Brit. J. Pharmacol. 12, 382 (1957).
Chamberlin, H. R., and R. E. Cooke: Organic phosphate anticholinesterase insecticide poisoning. Amer. J. Dis. Child. 85, 164–172 (1953).
Childs, A. F., D. R. Davies, A. L. Green and J. P. Rutland: The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Brit. J. Pharmacol. 10, 462–465 (1955).
Conley, B. E.: Health problems of vaporizing and fumigating devices for insecticides. J. Amer. med. Ass. 152, 1232–1234 (1953).
Craig, A. B., and G. S. Woodson: Observations on the effects of exposure to nerve gas. Clinical observations and cholinesterase depression. Amer. J. med. Sci. 238, 13–17 (1959).
Cullumbine, H., and P. Dirnhuber: Oral and bronchial fluids in poisoning with anticholinesterase. J. Pharm. (Lond.) 7, 580–585 (1955).
Davies, D. R.: Cholinesterases and the mode of action of some anticholinesterases. J. Pharm. (Lond.) 6, 1–26 (1954).
Davies, D. R., and A. L. Green: The chemotherapy of poisoning by organophosphate anticholinesterases. Brit. J. industr. Med. 16, 128–134 (1959).
Cullumbine, H., and P. Dirnhuber, and G. L. Willey: 2–Hydroxyiminomethyl-X-methylpyridinium methanesulphonate and atropine in the treatment of severe organophosphate poisoning. Brit. J. Pharmacol. 14, 1–5 (1959).
Cullumbine, H., P. Holland and M. J. Rumens: The relationship between the chemical structure and neurotoxicity of alkyl organophosphorus compounds. Brit. J.Pharmacol. 15, 271–278 (1960).
Cullumbine. H., and G. L. Willey: The toxicity of 2–hydroxyiminomethyl-N-methylpyridinium methanesulphonate (p2S). Brit. J. Pharmacol. 13, 202 (1958).
DeBurgh,M., and P. G. Wright: The effects of anticholinesterases upon peripheral vascular resistance in the dog. J. Physiol. (Lond.) 133, 475–497 (1956).
DeCandole, C. A., W. W. Douglas, E. C. Lovatt, R. Holmes, K. E. V. Spencer, R. W. Torrance and K. M. Wilson: The failure of respiration in death by anticholinesterase poisoning. Brit. J. Pharmacol. 8, 466–475 (1953).
Deichmann, W. B., P. Brown and C. Downing: Unusual protective action of a new emulsifier for the handling of organic phosphates. Science 116, 221 (1952).
Deichmann, W. B., and R. Rakoczy: Buscopan in treatment of experimental poisoning by parathion, methyl parathion and systox. A.M.A. Arch, industr. Hyg. 7, 152–156 (1953).
DelCastillo, J., and B. Katz: Biophysical aspects of neuromuscular transmission. Progr. Biophys. 6, 121–170 (1956).
Delga, J.: Les anticholinestérasiques organophosphores. Actualités Pharmacol. 10, 47–87 (1957).
Depierre, F., and Martin: Anticholinestérasiques. Protection in vitro par les ammonium quaterinaires. C. R. Acad. Sci. (Paris) 246, 1 183–186 (1958).
Dirnhuber, P., and H. Cullumbine: The effect of anticholinesterase agents on the rat’s blood pressure. Brit. J. Pharmacol. 10, 12–15 (1955).
Dixon, E. M.: Dilatation of the pupils in parathion poisoning. J. Amer. med. Ass. 163, 444–445 (1957).
Douglas, W. W., and P. B. V. Matthews: Acute tetraethylpyrophosphate poisoning in cats and its modification by atropine or hyoscine. J. Physiol. (Lond.) 116, 202–218(1952).
DuBois, K. P., J. Doull and J. M. Coon: Studies on the toxicity and pharmacological action of octamethyl pyrophosphoramide (OMPA: Pestox III) J. Pharmacol, exp. Ther. 99, 376–393 (1950).
Dultz, L., M. A. Epstein, G. Freeman, E. H. Gray and W. B. Weil: Studies on a group of oximes as therapeutic compounds in Sarin poisoning. J. Pharmacol, exp. Ther. 119, 522–531 (1957).
Durham, W. F., T. B. Gaines and W. J. Hayes jr.: Paralytic and related effects of certain organic phosphorus compounds. A.M.A. Arch, industr. Hlth 13, 326–330 (1956).
Durlacher, S. H., W. G. Banfield and A. D. Bergner: Post-mortem pulmonary edema. Yale J. Biol. Med. 22, 565–572 (1949/50).
Elam, J. O., E. S. Brown and J. D. Elder jr.: Artificial respiration by mouth to mask methods. A study of the respiratory gas exchange of paralyzed patients ventilated by operator’s expired air. New Engl. J. Med. 250, 749–754 (1954).
Elam, J. O., J. A. Clements, E. S. Brown and N. W. Elton: Artificial respiration for the nerve gas casualty. U. S. armed Forces med. J. 7, 797–810 (1956).
Elam, J. O., D. G. Green, M. A. Schneider, H. M. Ruben, A. S. Gordon, R. F. Hustead, D. W. Benson, J. A. Clements and A. Ruben: Head-tilt method of oral resuscitation. J. Amer. med. Ass. 172, 812–815 (1960).
E. S. Brown and J. A. Clements: Oxygen and carbon dioxide exchange and energy cost of expired air resuscitation. J. Amer. med. Ass. 167, 328–334 (1958).
Erdmann, W. D., u. D. Heye: Analyse der erregenden und lähmenden Wirkung von Alkvl-phosphaten (Parathion, Paraoxon, Systox) am isolierten Kaninchendarm. Naunyn- Schmiedeberg’s Arch. exp. Path. Pharmak. 232, 507–521 (1958).
Erdmann, W. D., U. L. Lendle: Vergiftungen mit esteraseblockierenden Insecticiden aus der Gruppe der organischen Phosphosaure-Ester (E 605 und Verwandte). Ergebn. inn. Med. Kinderheilk. 10, 104–184 (1958).
Fatt, P.: Biophysics of junctional transmission. Physiol. Rev. 34, 674 (1954).
Faust, J. : Poisoning due to tetraethylpyrophosphate. J. Amer. med. Ass. 141,192–193(1949).
Fleisher, J. H., J. P. Corrigan and J. W. Howard: Potentiation of the response of frog rectus muscle to acetyl choline by isopropyl methyl phosphonofiuoridate and its modification by pyridine-2–aldoxime methiodide. Brit. J. Pharmacol. 13, 291–295 (1958 a).
Fleisher, J. H., J. W. Howard and J. P. Corrigan: Effect of pyridine aldoximes on response of frog rectus muscle to acetylcholine. Brit. J. Pharmacol. 13, 288–290 (1958b).
Fredriksson, T.: Pharmacological properties of methyl-fluorophosphorylcholines. Two synthetic cholinergic drugs. Arch. int. Pharmacodyn. 113, 101–113 (1957).
Fredriksson, T.: Further studies on fiuoro-phosphorylcholines. Pharmacological properties of two new analogues. Arch. int. Pharmacodyn. 115, 474–482 (1958).
Freeman, G., and M. A. Epstein: Therapeutic factors in survival after lethal cholinesterase inhibition by phosphorus insecticides. New Engl. J. Med. 253, 266–271 (1955).
Friedman, A. M., and H. E. Himwich: Effect of age on lethality of di-isopropyl fiuoro-phosphate. Amer. J. Physiol. 153, 121–126 (1948).
Funke, A., F. Depierre and M. W. Krucker: Exaltation de l’activité anticholinestérasique des sels d’ammonium quaternaires des phenoxyacanes par l’introduction de groupements uréthanes. C. R. Acad. Sci. (Paris) 234, 762–764 (1952).
Glasson, J., and F. H. Stelling: An unusual cause for paralysis of the extremities. Report of prolonged paralysis due to anticholinesterase agent. Sth. Med. J. (Bgham, Ala.) 49, 1325 (1956).
Gold, A. J., J. M. Weller and G. Freeman: Metabolic and acid base changes following acute cholinesterase inhibition. Amer. J. Physiol. 188, 321–326 (1957).
Goldman, H., and M. Teitel: Malathion poisoning in a 34 month old child following accidental ingestion. J. Pediat. 52, 76–81 (1958).
Gordon, A. S., and C. W. Frye: Large doses of atropine. Low toxicity and effectiveness in anticholinesterase intoxication. J. Amer. med. Ass. 159, 1181–1184 (1955).
Gordon, A. S., and C. W. Frye, R. D. Miller and G. M. Wyant: Comparative methods of artificial respiration. U.S. armed Forces med. J. 6, 781–793 (1955).
Gordon, A. S., and C. W. Frye, L. Gittelson, M. S. Sadove and E. J. Beattie jr.: Mouth-to-mouth versus manual artificial respiration for children and adults. J. Amer. med. Ass. 167, 320–328 (1958).
Green, A. L., and H. J. Smith: The reactivation of cholinesterase inhibited with organophosphorus compounds. I. Reactivation by 2–oxoaldoximes. Biochem. J. 68, 28–31 (1958a).
Green, A. L., and H. J. Smith: The reactivation of cholinesterase inhibited with organophosphorus compounds. 2. Reactivation by pyridinealdoxime methiodides. Biochem. J. 68, 32–35 (1958b).
Green, A. L., R. 0. Bauer, C. D. Janney and J. O. Elam: Expired air resuscitation in paralyzed human subjects. J. appi. Physiol. 11, 313–318 (1957).
Green, A. L., J. O. Elam, I. L. Bunnell and J. L. Evers: The expired air ventilator. Amer. J. Surg. 97, 407–413 (1959).
Griesemer, R. D.: The penetration of an anticholinesterase agent (Sarin) into skin. III. A method for studying the rate of penetration into the skin of a living rabbit. J. invest. Derm. 31, 255–258 (1958).
Grob, D.: Uses and hazards of the organic phosphate anticholinesterase compounds. Ann. intern. Med. 32, 1229–1234 (1950a).
Grob, D.: The toxic effects in man of the organic phosphate insecticides (Report of the Committee on Pesticides of the Council on Pharmacy and Chemistrv of the Amer. Med. Assoc.). J. Amer. med. Ass. 144, 105–107 (1950b).
Grob, D.: The anticholinesterase activity in vitro of the insecticide, parathion (p-nitrophenyl diethyl thionophosphate). Bull. Johns Hopk. Hosp. 87, 95–105 (1950c).
Grob, D.: The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. A.M.A. Arch, intern. Med. 98, 221–239 (1956a).
Grob, D.: Manifestations and treatment of nerve gas poisoning in man. U.S. armed Forces med. J. 7, 781–789 (1956b).
Grob, D.: The neuromuscular system. Chapter 30 in Clinical Physiology, 725–756, ed. by Arthur Grollman. New York: McGraw-Hill Inc. 1957.
Grob, D.: Myasthenia gravis, current status of pathogenesis, clinical manifestations and management. J. chron. Dis. 8, 536–566 (1958).
Grob, D., J. L. Lilienthal, A. M. Harvey and B. F. Jones: The administration of diisopropyl fluorophosphate (DFP) to man. I. Effect on cholinesterase; general systemic effects; use in study of hepatic function and erythropoiesis; properties of plasma cholinesterase. Bull. Johns Hopk. Hosp. 81, 217–244 (1947a).
Grob, D. and A. M. Harvey: The administration of di-isopropyl fluorophosphate to man. II. Effect on intestinal motility and use in the treatment of abdominal distention. Bull. Johns Hopk. Hosp. 81, 245–256 (1947b).
Grob, D., A. M. Harvey, O. R. Langworthy and J. L. Lilienthal jr.: The administration of di-isopropyl fluorophosphate to man. III. Effect on the central nervous system, with special reference to the electrical activity of the brain. Bull. Johns Hopk. Hosp. 81, 257–266 (1947c).
Grob, D., W. L. Garlick, G. G. Merrill and H. C. Freimuth: Death due to parathion, an anticholinesterase insecticide. Ann. intern. Med. 31, 899–904 (1949).
Grob, D. and A. M. Harvey: Observations on the effects of tetraethyl pyrophosphate (TEPP) in man, and on its use in the treatment of myasthenia gravis. Bull. Johns Hopk. Hosp. 84, 532–567 (1949).
Grob, D., W. L. Garlick and A. M. Harvey: The toxic effects in man of the anticholinesterase insecticide, parathion. Bull. Johns Hopk. Hosp. 87, 107–129 (1950).
Grob, D., and A. M. Harvey: The effects and treatment of nerve gas poisoning. Amer. J. Med. 14, 52–63 (1953).
Grob, D., R. J. Johns and A. M. Harvey: Studies in neuromuscular function. I. Introduction and Methods. Bull. Johns Hopk. Hosp. 99, 115–124 (1956a).
Grob, D.: Studies in neuromuscular function. III. Stimulating and depressant effects of acetylcholine and choline in normal subjects. Bull. Johns Hopk. Hosp. 99, 136–152 (1956b).
Grob, D.: Studies in neuromuscular function. V. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in normal subjects. Bull. Johns Hopk. Hosp. 99, 195–218 (1956c).
Grob, D. and J. C. Harvey: Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. clin. Invest. 37, 350–368 (1958).
Grob, D., and R. J. Johns: Use of oximes in the treatment of intoxication by anticholinesterase compounds in normal subjects. Amer. J. Med. 24, 497–511 (1958a).
Grob, D. : Use of oximes in the treatment of intoxication by anticholinesterase compounds in patients with myasthenia gravis. Amer. J. Med. 24, 512–518 (1958 b).
Grob, D.: Treatment of anticholinesterase intoxication in normal subjects and myasthenic patients with oximes. J. Amer. med. Ass. 166, 1855–1858 (1958c).
Grob, D.: Treatment of anticholinesterase intoxication with oximes. Neurology 8, 897–902 (1958d).
Use of the oxime l,r-trimethylene bis (4–formylpyridinium bromide) dioxime (EA1814, TMB-4) in the management of intoxication by anticholinesterase compounds. Contractor’s Progress Report to U.S. Army Chemical Corps. Medical Laboratories, Army Chemical Center, Md., August (1958e).
Hamblin, D. O., and H. H. Golz: Parathion poisoning — A brief review. Industr. Med. Surg. 24, 65–72 (1955).
Harvey, A. M., J. L. Lilienthal jr., D. Grob, B. F. Jones and S. A. Talbot: The administration of disopropyl fluorophosphate to man. IV. The effects on neuromuscular function in normal subjects and in myasthenia gravis. Bull. Johns Hopk. Hosp. 81, 267–292 (1947).
Heymans, C., A. Pochet and H. van Houtte: Contributions ä la pharmacologic due Sarin et due Tabun. Arch. int. Pharmacodyn. 104, 293–332 (1956).
Himwich, H. E., C. F. Essig, J. L. Hampson, P. D. Bales and A. M. Freedman: Effect of trimethadione (Tridione) and other drugs on convulsions caused by di-isopropyl fluoro-phosphate (DFP). Amer. J. Psychiat. 106, 816–820 (1950).
Hobbiger, F., D. G. O’Sullivan and P. W. Sadler: New potent reactivators of acetylcholinesterase inhibited by tetraethyl pyrophosphate. Nature (Lond.) 182, 1498–1499 (1958).
Holmes, J. H.: Effect of exposure to Sarin or Parathion on blood coagulation. Progress report to U.S. Army Chemical Corps. Med. Laboratories, Army Chem. Center, Md. (1956).
Holmes, R., and E. L. Robins: The reversal by oximes of neuromuscular block produced by anticholinesterases. Brit. J. Pharmacol. 10, 490–495 (1955).
Holmstedt, B.: Synthesis and pharmacology of dimethylamido-ethoxy-phosphoryl cyanide (Tabun) together with a description of some allied anticholinesterase compounds containing the N—P bond. Acta physiol. scand. 25, 1–120 (1951).
Holmstedt, B.: Pharmocology of organophosphorus cholinesterase inhibitors. Pharmacol. Rev. 11, 567 to 688 (1959).
Holmstedt, B., L. Krook and J. R. Rooney: The pathology of experimental cholinesterase-inhibitor poisoning. Acta pharmacol. (Kbh.) 13, 337–344 (1957).
Hottinger, A., and H. Bloch: Über die Spezifität der Cholinesterase-Hemmung durch Tri-o-kresylphosphat. Helv. chim. Acta 26, 142–155 (1943).
Jager, B. V., G. N. Stagg, N. Green and L. Jager: Studies on distribution and disappearance of pyridine-2–aldoxime methiodide (PAM) and of diacetyl monoxime (DAM) in man and in experimental animals. Bull. Johns Hopk. Hosp. 102, 225–234 (1958).
Jager, B. V., G. N. Stagg, Toxicity of diacetyl monoxime and of pyridine-2–aldoxime methiodide in man. Bull. Johns Hopk. Hosp. 102, 203–211 (1958).
Jacques, R.: Entstehung von Magenulcera unter dem Einfluß von Cholinesterasegiften. Helv. physiol. pharmacol. Acta 12, C 24 (1954).
Jewell, H. A., and R. A. Lehman: Pharmacology of phospholine iodide—an alkyl phosphothio-choline. Fed. Proc. 17, 381 (1958).
Johnson, R. P., A. J. Gold and G. Freeman: Comparative lung-airway resistance and cardiovascular effects in dogs and monkeys following Parathion and Sarin intoxication. Amer. J. Physiol. 192, 581–584 (1958).
Karczmar, A. G., and J. P. Long: Relationship between peripheral cholinolytic potency and tetraethylpyrophosphate antagonism of a series of atropine substitutes. J. Pharmacol, exp. Ther. 123, 230–237 (1958).
Karlog, O., M. Nimb and E. Poulson: Parathion (bladan) forgiftning, behandlet med 2–PAM (pyridy 1–2–aldoxim-N-methyliodid). Ugeskr. Laeg. 120, 177–193 (1958).
Katz, B., and S. Thesleff: A study of the “desensitization” produced by acetylcholine at the motor end-plate. J. Physiol. (Lond.) 138, 63 (1957).
Kay, K., L. Monkman, J. P. Windisch, T. Doherty, J. Pare and C. Racicot: Parathion exposure and cholinesterase response of Quebec apple growers. A.M.A. Arch, industr. Hyg. 6, 252–262 (1952).
Kelensky, N. C., W. G. Moran, M. Feldstein and N. E. Fidler: Poisoning from TEPP. J. Amer. med. Ass. 149, 1015 (1952).
Kewitz, H., I. B. Wilson and D. Nachmansohn: A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties. Arch. Biochem. 64, 456 (1956).
Kewitz, H., and D. Nachmansohn: A specific antidote against lethal alkyl phosphate intoxication. IV. Effects in brain. Arch. Biochem. 66, 271 (1957).
Koelle, G. B.: Protection of cholinesterase against irreversible inactivation by di-isopropyl-fiuorophosphate in vitro. J. Pharmacol, exp. Ther. 88, 232–237 (1946).
Koelle, G. B.: Histochemical demonstration of reactivation of acetylcholinesterase in vivo. Science 125, 1195–1196 (1957a).
Koelle, G. B.: Histochemical demonstration of reversible anticholinesterase action at selective cellular sites in vivo. J. Pharmacol, exp. Ther. 120, 488–503 (1957 b).
Koelle, G. B., and A. Gilman: The chronic toxicity of di-isopropyl fiuorophosphate (DFP) in dogs, monkey and rats. J. Pharmacol, exp. Ther. 87, 435–448 (1946).
Koelle, G. B.: Anticholinesterase drugs. J. Pharmacol, exp. Ther. 95 (Part 2, Pharmacol. Rev.), 166–216 (1949).
Koelle, G. B., and E. C. Steiner: The cerebral distribution of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection. J. Pharmacol, exp. Ther. 118, 420–434 (1956).
Kondritzer, A. A.: Chemistry, detection and decontamination of nerve gases. U.S. armed Forces med. J. 7, 765–771 (1956).
Kosolapoff, G. M.: Organophosphorus compounds. New York: John Wiley Sons, Inc., and New York: Chapman Hall, Ltd. 1959.
Köster, R.: Synergisms and antagonisms between physostigmine and di-isopropyl fluorophosphate in cats. J. Pharmacol, exp. Ther. 88, 39–46 (1946).
Krivoy, W. A., E. R. Hart and A. S. Marrazzi: Further analysis of the actions of DFP and curare on the respiratory center. J. Pharmacol, exp. Ther. 103, 361 (1951).
Krop, S., and A. M. Kunkel: Observations on the pharmacology of the anticholinesterases sarin and tabun. Proc. Soc. exp. Biol. (N. Y.) 85, 530–533 (1954).
Ladell, W. S. S.: Treatment of anticholinesterase poisoning. Brit. Med. J. 1958, 141–142.
Lancaster, M. C.: A note on the demyelination produced in hens by dialkylfluoridates. Brit. J. Pharmacol. 15, 279–281 (1960).
Lehman, R. A., H. M. Fitch, L. P. Bloch, H. A. Jewell and M. E. Nicholls: Antidotes and potentiating agents for phospholine iodide. J. Pharmacol, exp. Ther. 128, 307–317 (1960).
Marr, W. G., and D. Grob: Some ocular effects of a new anticholinesterase agent, tetraethyl pyrophosphate (TEPP) and its use in the treatment of chronic glaucoma. Amer. J. Ophthal. 33, 904–908 (1950).
March, R. B., T. R. Fukuto, R, L. Metcalf and M. G. Maxon: Fate of P32 labeled malathion in the laying hen, white mouse and American cockroach. J. econ. Entom. 49, 185–195 (1956).
Maresch, W.: Die Vergiftung durch Phosphorsäureester (E 605, Parathion, Thophos). Arch. Toxikol. 16, 285–319 (1957).
Merrill, G. G.: Neostigmine toxicity. Report of fatality following diagnostic test for myasthenia. J. Amer. med. Ass. 137, 362 (1948).
Metcalf, R. L.: Organic insecticides. Their chemistry and mode of action. New York and London: Interscience Publishers 1955.
Metcalf, R. L.: Advances in pest control research. I. New York and London: Interscience Publishers 1957.
Michel, H. O.: An electrometric method for the determination of red blood cell and plasma cholinesterase activity. J. Lab. clin. Med. 34, 1564–1568 (1949).
Milles, H. L., and H. B. Salt: Parathion poisoning. Brit. Med. J. 1950 II, 444.
Moore, W. K. S.: Two cases of poisoning with di-isopropylfluorophosphate (DFP). Brit. J. industr. Med. 13, 214–216 (1956).
Murtha, E. F., B. P. McNamara, G. E. Gorblewski and J. H. Wills: Site of action of magnesium in treatment of some toxic effects produced by TEPP. Proc. Soc. exp. Biol. (N. Y.) 90, 505–507 (1955).
Namba, T., and K. Hiraki: PAM (pyridine-2–aldoxime methiodide) therap for alkylphos-phate poisoning. J. Amer. med. Ass. 166, 1834–1839 (1958).
Nolan, K., and F. Wilcoxon: Method of bioassay for traces of parathion. Reprint from Agricultural Chemicals (1950).
Oberst, F. W., and M. K. Christensen: Regeneration of erythrocyte and brain cholinesterase activity in rats after sublethal exposures to GB vapor. J. Pharmacol, exp. Ther. 116 216–219 (1956).
Oberst, F. W., R. S. Ross, M. K. Christensen, J. W. Crook, P. Cresthull and C. W. Unland: The use of atropine and artificial respiration in the resuscitation of dogs exposed by inhalation to lethal concentrations of GB vapor. J. Pharmacol, exp. Ther. 116, 44–45 (1956).
O’Leary, J. F., J. H. Wills and L. A. Carlstrom: Relative efficacy of various prophylactic adjuncts to atropine in Sarin poisoning. Fed. Proc. 17, 401 (1958).
Osserman, K. E., P. Teng and L. I. Kaplan: Studies in myasthenia gravis. Preliminary report on therapy with Mestinon bromide. J. Amer. med. Ass. 155, 961 (1954).
Parkes, M. W., and P. Sacra: Protection against the toxicity of cholinesterase inhibitors by acetylcholine antagonists. Brit. J. Pharmacol. 9, 299–305 (1954).
Pateisky, K., E. Herzfelt and C. Stumpf: Der Effekt von Polymethylen-bis-(N-methyl-carbaminolyl-m-trimethylammoniumphenolen) BC40, BC47, BC48 auf Cholinesterase-aktivität und Muskeltätigkeit bei Myasthenia gravis pseudoparalytica. Wien. klin. Wschr. 69, 2–7 (1957).
Pateisky, K., O. Kraupp and C. Stumpf: Klinische Erfahrungen mit Hexamethylen-bis-(N-methyl-carbaminoyl-m-trimethylammoniumphenol) (BC40) bei Myasthenia gravis pseudoparalytica. Wien. klin. Wschr. 67, 578 (1955).
Petry, H.: Polyneuritis durch E 605. Zentralblatt für Arbeitsmedizin und Arbeitschutz 1, 86–89 (1951).
Petty, C. S.: Organic phosphate insecticide poisoning. Amer. J. Med. 24, 467–470 (1958).
Polet, H.: Effect of Sarin on the cardio-inhibitory, vasomotor and respiratory centers of the isolated head in dogs. Arch. int. Pharmacodyn. 118, 231–247 (1959).
Poziomek, E. J., B. E. Hackley jr., and G. M. Steinberg: Pyridinium aldoximes. J. org. Chem. 23, 714–717 (1958).
Quinby, G. E., and A. B. Lemmon: Parathion residues as a cause of poisoning in crop workers pesticidal spray. J. Amer. med. Ass. 166, 740–746 (1958).
Rajapurkar, M. V., and G. B. Koelle: Reactivation of DFP-inactivated acetylcholinesterase by monoisonitrosoacetone (MINA) and diacetylmonoxime (DAM) in vivo. J. Pharmacol, exp. Ther. 123, 247–253 (1958).
Rider, J. A., S. Schulman, R. B. Richter, H. C. Moeller and K. P. DuBois: Treatment of myasthenia gravis with octamethyl pyrophosphoramide. J. Amer. med. Ass. 145, 967–972 (1951).
Riker, W. F. jr., and W. C. Wescoe: The relationship between cholinesterase inhibition and function in a neuro-effector system. J. Pharmacol, exp. Ther. 95, 515–527 (1949).
Riker, W. F. jr., and W. C. Wescoe: The direct action of prostigmine on skeletal muscle; its relationship to the choline esters. J. Pharmacol, exp. Ther. 88, 58–77 (1946).
Rubin, L. S., and M. N. Goldberg: Effect of Sarin on dark adaption in man: threshold changes. J. appl. Physiol. 11, 439–444 (1957).
Rubin, L. S., and M. N. Goldberg: Effect of tertiary and quaternary atropine salts on absolute scotopic threshold changes produced by an anticholinesterase (Sarin). J. appl. Physiol. 12, 305–310 (1958).
Rubin, L. S., S. Krop and M. N. Goldberg: Effect of Sarin on dark adaptation in man. Mechanism of action. J. appl. Physiol. 11, 44549 (1957).
Rutland, J. P.: The effect of some oximes in sarin poisoning. Brit. J. Pharmacol. 13, 399–403 (1958).
Safar, P.: Mouth-to-mouth airway. Anesthesiology 18, 904 (1957).
Safar, P.: Ventilatory efficacy of mouth-to-mouth artificial respiration. J. Amer. med. Ass. 167, 335 to 341 (1958).
Safar, P., L. A. Escarrago and J. O. Elam: A comparison of the mouth-to-mouth and mouth-to-airway methods of artificial respiration with the chest-pressure arm-lift methods. New Engl. J. Med. 258, 671–677 (1958).
Sanderson, D.M.: Assessment of direct cholinesterase inhibitory activity of pupillary miosis. J. Pharm. (Lond.) 9, 600–604 (1957).
Schaumann, W., and C. Job: Differential effects of quaternary cholinesterase inhibitor, phos-pholine, and its tertiary analogue, compound 217-AO, on central control of respiration and on neuromuscular transmission. The antagonism by 217-AO of the respiratory arrest caused by morphine. J. Pharmacol, exp. Ther. 123, 114–120 (1958).
Schwab, R. S., C. K. Marshall and W. H. Timberlake: WIN 8077 in treatment of myasthenia gravis, use of N,N’bis (2–diethyl-aminoethyl) oxamide bis-2-chlorobenzyl chloride in 50 patients. J. Amer. med. Ass. 158, 625–628 (1955).
Shelley, H.: A correlation between cholinesterase inhibition and increase in muscle tone in rabbit duodenum. Brit. J. Pharmacol. 10, 26–35 (1955).
Sleisenger, M. H., C. M. Lewis, J. H. Pert, D. R. Roseman, W. F. Nichem and T. P. Almy: Use of parasympathetic stimulation in the production of bloody diarrhea in dogs, with reference to the role of red cell and colon cholinesterase. Gastroenterology 34, 582–594 (1958).
Smith, H. V., and M. J. Spalding: Outbreak of paralysis in Morocco due to ortho-cresyl phosphate poisoning. Lancet 1959 II, 1019–1021.
Snyder, G. H.: Encephalopathy in a child following exposure to Malathion. Ochsner Clin. Rep. 37 (1956).
Sprague, F., R. J. Johns and D. Grob: Unpublished observations (1958).
Summerson, W. H.: Progress in the biochemical treatment of nerve gas poisoning. U.S. Armed forces chem. J. 24–26 (1955).
Sumerford, W. H., J. Wayland, M. J. Johnston and K. J. Walker: Cholinesterase response and symptomatology from exposure to organic phosphorus insecticides. A.M.A. Arch. Hyg. Occup. Med. 7, 383–398 (1953).
Süsser, M., and Z. Stein: An outbreak of tri-ortho-cresyl phosphate (T.O.C.P.) poisoning in Durban. Brit. J. industr. Med. 14, 111–120 (1957).
Thompson, J. H.: Cholinesterase inhibiting insecticides (Parathion). Calif. Med. 82, 91–95 (1955).
Upholt, W. M., G. E. Quinby, G. S. Batchelor and J. P. Thompson: Visual effects accompanying TEPP-induced miosis. A.M.A. Arch. Ophthal. 56, 128–134 (1956).
Varagic, V.: The action of eserine on the blood pressure of the rat. Brit. J. Pharmacol. 10, 349–353 (1955).
Walker, M. B.: Treatment of myasthenia gravis with physostigmine. Lancet 1934 I, 1200–1201.
Walters, M. N. I.: Malathion intoxication. Med. J. Aust. 44, 876–880 (1957).
Weller, J. M., T. J. Miranda, M. Levine and G. Freeman: Effect of cholinesterase inhibitors on electrolyte distribution in vivo. Proc. Soc. exp. Biol. (N. Y.) 90, 699–702 (1955).
Wescoe, W. C., R. E. Green, B. P. McNamara and S. Krop: The influence of atropine and scopolamine on the central effects of DFP. J. Pharmacol, exp. Ther. 92, 63–72 (1948).
Wilhelmi, G., u. R. Domenjoz: Therapeutische Möglichkeiten bei der Parathion-Vergiftung. Arch. int. Pharmacodyn. 86, 321–334 (1951).
Williams, J. W., and J. T. Griefiths jr.: Parathion poisoning in Florida Citrus. J. Fla. med. Ass. 37, 707–709 (1951).
Wills, J. H., and R. V. Brown: The pharmacology of nerve gas poisoning. U.S. Armed forces chem. J. 11, 24–26 (1957).
Wills, J. H., A. M. Kunkel, R. V. Brown and G. E. Groblewski: Pyridine-2-aldoxime methiodide and poisoning by anticholinesterases. Science 125, 743–744 (1957).
Wilson, I. B.: Acetylcholinesterase. XI. Reversibility of tetraethyl pyrophosphate inhibition. J. biol. Chem. 190, 111–117 (1951).
Wilson, I. B.: Designing of a new drug with antidotal properties against the nerve gas Sarin. Biochem. biophys. Acta 27, 196–199 (1958).
Wilson, I. B., and E. K. Meislich: Reactivation of acetylcholinesterase inhibited by alkylphosphates. J. Amer. chem. Soc. 75, 4, 528 (1953).
Wilson, I. B.: S. Ginsburg and E. K. Meislich: The reactivation of acetylcholinesterase inhibited by tetraethyl pyrophosphate and diisopropyl fluorophosphate. J. Amer. chem. Soc. 77, 4286–4291 (1955).
Wirth, W.: Zur Wirkung system-insecticider Phosphorsäure-ester im Warmbluter-Stoffwechsel. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 234, 352–363 (1958).
Wishahi, A.: Parathion (phosphorus compound) poisoning. Arch. Pediat. 75, 387 (1958).
Wright, P. G.: An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit. J. Physiol. (Lond.) 125, 52–70 (1954).
Yamada, M.: Alkyl phosphate poisoning. III. Effect of 2-pyridinealdoxime methiodide in the therapy of parathion poisoning. Okayama Igakkai Zasshi 69, 525–539 (1957).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1963 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grob, D. (1963). Anticholinesterase Intoxication in Man and its Treatment. In: Koelle, G.B. (eds) Cholinesterases and Anticholinesterase Agents. Handbook of Experimental Pharmacology, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99875-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-99875-1_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99877-5
Online ISBN: 978-3-642-99875-1
eBook Packages: Springer Book Archive